Cellular delivery of impermeable effector molecules in the form of conjugates with peptides capable of mediating membrane translocation.
about
Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cyclin association and inhibitor designTreatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptideDiels-Alder cycloadditions in water for the straightforward preparation of peptide-oligonucleotide conjugatesHelix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactionsSite-specific sonoporation of human melanoma cells at the cellular level using high lateral-resolution ultrasonic micro-transducer arrays.An experimental and theoretical analysis of ultrasound-induced permeabilization of cell membranes.Membrane translocation of penetratin and its derivatives in different cell lines.Amphipathic peptides and drug delivery.Fatty acyl moieties: improving Pro-rich peptide uptake inside HeLa cells.Delivery of TAT/PTD-fused proteins/peptides to islets via pancreatic duct.Cell penetrating peptide inhibitors of nuclear factor-kappa B.Synthetic and natural polycationic polymer nanoparticles interact selectively with fluid-phase domains of DMPC lipid bilayers.An actin-ribonucleoprotein interaction is involved in transcription by RNA polymerase II.Multivalent dendritic polyglycerolamine with arginine and histidine end groups for efficient siRNA transfection.Molecular transporters: synthesis of oligoguanidinium transporters and their application to drug delivery and real-time imaging.Synthesis and evaluation of tripodal peptide analogues for cellular delivery of phosphopeptidesPeptide, Peptidomimetic, and Small-molecule Antagonists of the p53-HDM2 Protein-Protein Interaction.Intracellular transduction using cell-penetrating peptides.Nanomaterials for targeted drug delivery to cancer stem cells.Immunomodulation of cell-penetrating tat-metallothionein for successful outcome of xenotransplanted pancreatic islet.Endocytosis and membrane potential are required for HeLa cell uptake of R.I.-CKTat9, a retro-inverso Tat cell penetrating peptide.Bead-based cellular analysis, sorting and multiplexing.Cytostatic activity of 1,10-phenanthroline derivatives generated by the clip-phen strategy.Calpastatin exon 1B-derived peptide, a selective inhibitor of calpain: enhancing cell permeability by conjugation with penetratin.Probing nanoscale self-assembly of nonfluorescent small molecules inside live mammalian cells.A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency.Cytoplasmic and nuclear delivery of a TAT-derived peptide and a beta-peptide after endocytic uptake into HeLa cells.Vesicular disruption of lysosomal targeting organometallic polyarginine bioconjugates.Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans.
P2860
Q24556671-D16F125C-CF51-443B-BF63-B9C2C2D3C1A4Q24796110-290EF8D3-48E6-4DF9-8254-25B142398405Q25255749-368B71FD-CE1A-428C-9F00-85DBAE7871B2Q27642107-BEBAC150-0548-4AA6-9995-2C8B7D64C568Q30463547-600A36E0-E675-4A51-A228-08ED0AB587F2Q30503526-5E8A7BC9-03A6-45E5-927A-B205B318A767Q30881434-72BF9136-798F-4CFB-8054-93E04EB60503Q30917891-9B2FADCA-3294-4976-BF5A-CB7C532DD715Q33214906-F680813A-801A-46D6-BA40-7164CAACFC37Q33220618-EF65E759-794D-424A-989E-D167D0BFB727Q34289086-32500271-5A9F-438B-B36A-BDBD5C8E411BQ34545352-FAD6EB83-1AE0-4613-82BE-53439C77BB45Q35143311-4B10D135-D409-45FE-8E02-353F21DF28E1Q35728700-BC305C7E-C6E7-4E6B-A774-B0A651208A63Q36593381-91F1EF50-FE65-42DF-A4E8-6B58ADD78247Q36883621-AC6F397A-1DDA-490F-A830-FDF64C276F20Q37262594-B62DE693-06DD-4F86-9638-6590BF8203F2Q37710990-7A46C8EE-15D6-464E-BE04-1A069B4595AFQ38201740-73B640FB-EC38-4554-BB12-A7DE28AFB36EQ38797013-10057210-1413-447D-B99E-02FD8B139CF5Q40199589-3C5E9001-A14E-40DD-A372-D07BCD8E9386Q40405869-762EDBB9-0EC7-4955-8A05-1EFB90B6D2D7Q40447874-606D676C-45B3-41BC-9F84-4703F32DC70BQ40652159-9554CCDE-11F4-4735-A5F2-D17FB529F139Q41850356-02E79E3E-D6B6-4F5E-9368-03E21B6B76E5Q42952023-07CFBF2F-B4EF-45E7-A957-4AD854BC3947Q44601156-5BCB4483-3F5F-4423-A53C-518A6BAE2F20Q46783979-98DBACD7-AC9B-4E8E-9052-4095CF2B8EBFQ47448961-184A1621-9D12-4C71-81DD-90A7F9BD4C7C
P2860
Cellular delivery of impermeable effector molecules in the form of conjugates with peptides capable of mediating membrane translocation.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cellular delivery of impermeab ...... iating membrane translocation.
@ast
Cellular delivery of impermeab ...... iating membrane translocation.
@en
Cellular delivery of impermeab ...... iating membrane translocation.
@nl
type
label
Cellular delivery of impermeab ...... iating membrane translocation.
@ast
Cellular delivery of impermeab ...... iating membrane translocation.
@en
Cellular delivery of impermeab ...... iating membrane translocation.
@nl
prefLabel
Cellular delivery of impermeab ...... iating membrane translocation.
@ast
Cellular delivery of impermeab ...... iating membrane translocation.
@en
Cellular delivery of impermeab ...... iating membrane translocation.
@nl
P356
P1476
Cellular delivery of impermeab ...... diating membrane translocation
@en
P2093
P304
P356
10.1021/BC0155115
P577
2001-11-01T00:00:00Z